In addition to monitoring, a biobank will be incorporated with esophageal biopsies performed during endoscopies and blood tests, in order to detect protein and epigenetic markers to allow prediction of future disease.
This project has received funding from the Agence Nationale de la Recherche program France 2030 under a specific grant agreement.
AFAO, The French family support group, is part of the TransEAsome project.
*CRACMO is the French Reference Center for Congenital Esophageal abnormalities. It was founded in 2006 as part of the National Rare Disease Charter and is based in Lille University Hospital. This hospital has vast experience in surgery and multidisciplinary follow up of EA patients.
We comply with the HONcode standard for health trustworthy information
We are grateful for the financial support of EAT website
The 7th international Conference on EA will be held in Istambul, Turkey, in 2025.